International Flavors & Fragrances Inc.

International Flavors & Fragrances Inc. Earnings Recaps

IFF Materials 2 recaps
Q1 2026 May 7, 2026

IFF’s shares rose 10.6% following the first quarter, driven by better-than-expected volume growth across all segments, strong margin expansion, and improved cash flow despite ongoing global uncertainties.

Key takeaways
  • Revenue grew 3% to over $2.7 billion, supported by mid-single-digit volume growth in Health & Biosciences and low single-digit increases across Taste, Food Ingredients, and Scent.
  • Adjusted EBITDA rose 8% to $568 million, with EBITDA margin expanding 110 basis points to 20.7%, the highest since Q2 2022, fueled by productivity improvements and favorable pricing.
  • Taste segment sales increased 2% with an 18% EBITDA gain, led by volume and pricing strength, particularly in Greater Asia.
  • Food Ingredients posted 3% sales growth and a 12% EBITDA increase, driven by strong volume (5%) and productivity; volume growth was the highest in several years.
  • Health & Biosciences delivered 5% volume-driven sales growth across most businesses and 7% EBITDA growth, reflecting robust demand in Animal Nutrition and Food Biosciences.
Q3 2025 Nov 6, 2025

IFF delivered steady third quarter results, maintaining sales at approximately $2.7 billion despite a challenging macro environment. The company achieved a 7% increase in adjusted operating EBITDA, reflecting solid profitability and strategic investments for future growth.

Key takeaways
  • Sales held flat year-over-year, with Scent and Taste businesses showing mid- and low single-digit growth, respectively.
  • Adjusted operating EBITDA rose 7%, with an improved margin of 130 basis points, underscoring effective cost management.
  • Significant progress on strategic initiatives, including new innovation centers and collaborations with BASF and Kemira, poised to enhance market offerings.
  • The company reduced net debt to EBITDA ratio to approximately 2.5x and authorized a $500 million share repurchase, indicating a disciplined capital allocation approach.
  • Year-to-date sales growth of 2% and ongoing portfolio optimization efforts, including completed divestitures, support IFF's long-term financial goals.